Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer Risk Factors
Higher enterolactone levels may reduce breast cancer risk
November 10th, 2005
Higher enterolactone levels may reduce breast cancer risk, but recent study shows it is not through lowering mammographic density. "Certain phytoestrogens, such as lignans, may protect against developing breast cancer. Enterolactone is a lignan metabolite produced by the intestinal flora from dietary precursors such as whole grains, vegetables, and fruits," explained researchers from Norway. "Enterolactone has been shown to have weak estrogenic and antiestrogenic properties." A. Stuedal and colleagues "decided to examine the association between plasma levels of enterolactone and mammographic density, a biomarker for breast cancer risk. They included...
Source: Women's Health Weekly (2005-11-10)
|
